Nonbenzodiazepine anticonvulsants

28,045views

Nonbenzodiazepine anticonvulsants

Watch later

Watch later

Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Resting membrane potential
Gene regulation
Epigenetics
Nuclear structure
DNA structure
Transcription of DNA
Amino acids and protein folding
Necrosis and apoptosis
Endometrial hyperplasia and cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Lung cancer
Asthma
Atrial septal defect
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Cor pulmonale
Heart failure: Pathology review
Myocarditis
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Abnormal uterine bleeding: Clinical
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Benign prostatic hyperplasia
Thyroid hormones
Testosterone
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Primary adrenal insufficiency
Hyperthyroidism: Pathology review
Chronic leukemia
Anemia of chronic disease
Hemophilia
Heparin-induced thrombocytopenia
Hypocalcemia
Hypermagnesemia
Hypokalemia
Hypomagnesemia
Inflammation
Innate immune system
Complement system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute pyelonephritis
Celiac disease
Cirrhosis
Congenital disorders: Clinical
Appendicitis
Autoimmune hepatitis
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Crohn disease
Gastroesophageal reflux disease (GERD)
Nephrotic syndromes: Pathology review
Irritable bowel syndrome
Lower urinary tract infection
Biliary colic
Peptic ulcer
Renal failure: Pathology review
Urinary tract infections: Pathology review
Viral hepatitis
Pancreatitis: Pathology review
Alcohol-associated liver disease
Ulcerative colitis
Medullary cystic kidney disease
Small bowel ischemia and infarction
Chronic kidney disease
Acute cholecystitis
Skin cancer
Autosomal trisomies: Pathology review
Selective permeability of the cell membrane
Free radicals and cellular injury
Pericarditis and pericardial effusion
Peripheral artery disease
Cauda equina syndrome
Cranial nerves
Dementia: Pathology review
Arteriovenous malformation
Bipolar and related disorders
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Alzheimer disease
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Coagulation disorders: Pathology review
Factor V Leiden
Hodgkin lymphoma
Disseminated intravascular coagulation
Non-Hodgkin lymphoma
Introduction to the immune system
Acute pancreatitis
Approach to congenital heart diseases (acyanotic): Clinical sciences
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Anthelmintic medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Antituberculosis medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Anti-parkinson medications
Tricyclic antidepressants
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Approach to viral exanthems (pediatrics): Clinical sciences
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus

Transcript

Watch video only

Anticonvulsants are a type of medication used to treat the various types of seizure disorders.

These include benzodiazepines and barbiturates which increase the activity of inhibitory neurons, but there are also many other classes of anticonvulsants with different mechanisms that we’ll talk about in this video.

Okay, so the cells that make up our brain are called neurons.

Neurons communicate with each other through neurotransmitters.

When one neuron is stimulated, it releases excitatory neurotransmitters that bind to receptors on the next neuron. This causes the next neuron to depolarize and release its own excitatory neurotransmitters, propagating the signal throughout the brain.

The main excitatory neurotransmitter in our brain is glutamate which can bind to several types of receptors that are basically ligand-gated ion channels, which open up and allow Na+ and Ca2+ to flow in, and K+ to flow out.

In the end, when it’s all added up, there’s an influx of positive charge that makes the cell less negative,and the neuron becomes depolarized. This causes nearby voltage-gated Na+ channels to open on the surface of the membrane, causing more Na+ to enter. This in turn triggers other nearby voltage-gated Na+ channels to open.

So this series of depolarization travels down the neuron like a wave and it’s called an action potential.

When it reaches the end of the neuron, called the synaptic terminal, it triggers the opening of voltage-gated Ca2+ channels, causing an influx of calcium ions which stimulates the release of neurotransmitters that are stored in synaptic vesicles.

Okay, we also have inhibitory neurons that shut down this chain of events.

These neurons release the main inhibitory neurotransmitter called gamma-aminobutyric acid or GABA, which binds to GABA receptors on other neurons.

These GABA receptors are also ligand-gated ion channels, but they open up to let the negatively charged Cl-, into the cell.

The influx of negative ions causes hyperpolarization where the cell’s membrane potential becomes more negative, which means it’s much more difficult for it to depolarize and fire off an action potential.

Alright, now there are cases where neurons in the brain start sending out more excitatory signals than normal. This can occur due to either too much excitation or too little inhibition in the brain.

Excessive excitatory signals can cause a variety of disorders like seizures and epilepsy.

Seizures are categorized based on the region of the brain that’s affected.

When it’s limited to one hemisphere or a single lobe, we call it a focal or partial seizure, and these can cause the person to experience strange sensations, like hearing or tasting something that isn’t there, but can also involve jerking movements in specific muscle groups if the neurons controlling these muscles are affected.

A generalized seizure is where both hemispheres of the brain are affected.

Tonic-clonic seizures are the most common generalized seizures, where patients experience a tonic phase, where the muscles suddenly tense up, followed by the clonic phase, where the muscles rapidly contract and relax.

Another type of generalized seizure is absence seizures, where the person has impaired awareness or responsiveness, generally with the only outward sign being that the person looks like they “spaced out.”

If the seizures themselves last longer than 5 minutes without stopping, or if there are multiple seizures without returning to normal in between, then it’s called status epilepticus.

Okay, so we can manage seizure disorders by increasing the effect of inhibitory neurons or decreasing the activity of excitatory neurons.

Let’s start with a group of medications that block voltage-gated sodium channels, which inhibit the action potentials in excitatory neurons. These include carbamazepine, valproic acid, phenytoin, lamotrigine, and topiramate. Some of these medications have other mechanisms as well.

Lamotrigine and topiramate inhibit the release of glutamate; and topiramate also inhibits voltage-gated calcium channels.

Valproic acid inhibits GABA transaminase, which is an enzyme that breaks down GABA in the inhibitory neurons.

So valproic acid inhibits the metabolism of GABA, increases GABA concentration in the brain and enhances the effect of inhibitory neurons.

Okay moving on to indications. Carbamazepine, valproic acid, lamotrigine, topiramate and phenytoin are commonly used for the treatment of partial and generalized tonic-clonic seizures.

In addition, lamotrigine and valproic acid are used for absence seizures.

For the prophylaxis of status epilepticus, phenytoin and its prodrug, fosphenytoin, are considered the medications of choice.

Apart from seizures and epilepsy, carbamazepine, lamotrigine, and valproic acid are also used as mood stabilizers for bipolar disorder.

Note also that carbamazepine is the first line treatment for trigeminal neuralgia which is a disorder characterized by shooting pain in the distribution of the trigeminal nerve.

Finally, valproic acid and topiramate are also used as prophylactic therapy for migraines and cluster headaches.

Alright let’s move on to side effects. Carbamazepine can cause diplopia or double vision, ataxia, agranulocytosis, liver toxicity, and SIADH or syndrome of inappropriate antidiuretic hormone secretion.

A rare but potentially fatal side effect of carbamazepine is Stevens Johnson syndrome, which is characterized by rapid desquamation of the skin.

Note also that carbamazepine is not safe to use during pregnancy because it increases the risk of congenital defects like cleft lip or palate, and neural tube defects such as spina bifida.

Also, carbamazepine induces a class of enzymes called cytochrome P450. These enzymes are involved in the metabolism of various medications like benzodiazepines, phenytoin, quinidine, warfarin, and others. Increased cytochrome P450 activity can result in these medications being broken down too rapidly, so larger doses are needed to achieve a therapeutic effect.

Okay, now common side effects of lamotrigine include blurred vision and gastrointestinal symptoms, like nausea and vomiting.

If levels increase, lamotrigine can cause Stevens Johnson syndrome and thus serum levels should be monitored closely.

Now side effects of phenytoin include visual disturbances like nystagmus, or involuntary eye movement; diplopia; ataxia; hirsutism or excessive hair growth; and gingival hyperplasia or enlarged gums.

Phenytoin also inhibits the absorption of folate in the small intestine and so it can lead to megaloblastic anemia.

In addition, phenytoin induces cytochrome P450 just like carbamazepine.

Rare adverse effects include Stevens Johnson syndrome and symptoms that mimic systemic lupus erythematosus, or SLE-like syndrome.

Keep in mind that phenytoin is not safe to use during pregnancy.

Teratogenic effects include intrauterine growth restriction or IUGR, intellectual disability, cleft lip or palate, and congenital heart defects.

Common side effects of valproic acid are gastrointestinal symptoms like nausea and vomiting, tremors, sedation, alopecia or loss of hair, weight gain, and blood disorders like a low platelet and white blood cell count.

A rare but life-threatening adverse effect is liver toxicity.

Key Takeaways

Nonbenzodiazepine anticonvulsants are a class of drugs used to treat seizures, headaches, and neuropathic pain. These drugs are also used as mood stabilizers for bipolar disorders. Nonbenzodiazepine anticonvulsants decrease excitatory signals in the brain, primarily by blocking sodium and calcium channels, or by enhancing the actions of GABA. This lead to a decrease in the abnormal electrical activity in the brain responsible for the associated symptoms.

Common examples of nonbenzodiazepine anticonvulsants include carbamazepine, lamotrigine, and valproic acid. Side effects include double vision, ataxia, and liver toxicity for carbamazepine; Stevens Johnson syndrome for lamotrigine; and teratogenic effects like neural tube defects for valproic acid.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents" Cochrane Database Syst Rev (2017)
  5. "Adverse effects of antiepileptic drugs: a brief overview of important issues" Expert Rev Neurother (2010)
  6. "Antiepileptic action induced by a combination of vigabatrin and tiagabine" Neuroscience (2005)